Targeted Medical Pharma (Targeted Medical Pharma) Valuation Rank

View and export this data going back to 2012. Start your Free Trial

What is Targeted Medical Pharma Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

Three factors:
- Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
- Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
- Industry relative valuation
Companies without enough data is not ranked
Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Targeted Medical Pharma Valuation Rank Related Terms

Thank you for viewing the detailed overview of Targeted Medical Pharma's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Targeted Medical Pharma (Targeted Medical Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Targeted Medical Pharma Inc (OTCPK:TRGM) » Definitions » Valuation Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

2980 Beverly Glen Circle, Los Angeles, CA, USA, 90077

Website

http://www.tmedpharma.com

Targeted Medical Pharma Inc is a United States based specialty pharmaceutical company, which develops and commercializes amino acid-based medications. The business activities of the group are functioned through Targeted Medical Pharma; Complete Claims Processing, Inc. and Amino Nutritionals segments. The operations of the group are primarily functioned through the region of United States and it derives the majority of revenue from Targeted Medical Pharma segment which develops and distributes amino acid-based therapeutic products and distributes pharmaceutical products from other manufacturers through employed sales representatives, independent distributors, and pharmacies.

Executives

William B. Horne	officer: Chief Financial Officer	C/O AULT ALLIANCE, INC., 940 SOUTH COAST DRIVE, SUITE 200, COSTA MESA CA 92626
Maurice J Dewald	director	C/O TARGETED MEDICAL PHARMA, INC., 2980 BEVERLY GLEN CIRCLE, SUITE 100, LOS ANGELES CA 90077
Scott Gottlieb	director	MOLECULAR INSIGHT PHARMACEUTICALS, 160 SECOND STREET, CAMBRIDGE MA 02142
Ronald W Rudolph	officer: See Remarks	C/O TARGETED MEDICAL PHARMA, INC, 2980, BEVERLY GLEN CIRCLE, SUITE 301, LOS ANGELES CA 90077
Amir F Heshmatpour	director, 10 percent owner, officer: Former President	C/O AFH HOLDING & ADVISORY LLC, 9595 WILSHIRE BLVD, STE 900, BEVERLY HILLS CA 90212
John H Bluher	director	12981 NORTH 2ND STREET, PARKER CO 80134
Steve B Warnecke	officer: Chief Financial Officer	C/O TARGETED MEDICAL PHARMA, INC., 2980 BEVERLY GLEN CIRCLE, SUITE 301, LOS ANGELES CA 90077
Afh Holding & Advisory, Llc	10 percent owner, other: Former 10% Owner	269 S. BEVERLY DRIVE, STE #1600, BEVERLY HILLS CA 90212
Timothy Brasel	director, officer: Vice President	16178 EAST PRETENCE PLZ, AURORA CO 80015